Huang, Weishan
- Louisiana State University, Baton Rouge · Pathology (NIH department code)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
FY2023 NIH rank #21,313
- R01 Holder
- Early Career
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2018 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2023 award categories
- Pathology
NIH Funding · FY2023
Linked Award Amount
$574.6K
Full award amounts, FY2023
Award Records
2
Records listing this PI
Award-Linked Rank
#21,313
By linked amount among FY2023 PIs
Earliest Year Loaded
2018
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2023 award records by amount
NIH award records listing Huang, Weishan as a PI. Multi-PI records show the full award amount for context.
- 5R01AI151139-03R01Contact PIMarkers and regulation of regulatory CD8+ T cells during influenza-induced lung immunopathologyLouisiana State University, Baton Rouge · Pathology (NIH department code)$371.4Kaward amount
- 1R21AI166898-01A1R21Contact PIProgramming designer DNA nanostructures for blocking enveloped viral infectionLouisiana State University, Baton Rouge · Pathology (NIH department code)$203.1Kaward amount
Award organization
Organizations that administered FY2023 awards listing Huang, Weishan as a PI.
FY2023 award administered by Louisiana State University, Baton Rouge (LA).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2018First NIH AwardLouisiana State University, Baton Rouge
- 2019R01 Grant Holder
- 2021$500K Cumulative Funding
- 2022$1M Cumulative Funding